| 10-year follow-up of intensive glucose control in type 2 diabetes RR Holman, SK Paul, MA Bethel, DR Matthews, HAW Neil New England journal of medicine 359 (15), 1577-1589, 2008 | 10037 | 2008 |
| Intensive glucose control and macrovascular outcomes in type 2 diabetes FM Turnbull, C Abraira, RJ Anderson, RP Byington, JP Chalmers, ... Diabetologia 52, 2288-2298, 2009 | 1388 | 2009 |
| DALI: defining antibiotic levels in intensive care unit patients: are current β-lactam antibiotic doses sufficient for critically ill patients? JA Roberts, SK Paul, M Akova, M Bassetti, JJ De Waele, G Dimopoulos, ... Clinical infectious diseases 58 (8), 1072-1083, 2014 | 1048 | 2014 |
| Long-term follow-up after tight control of blood pressure in type 2 diabetes RR Holman, SK Paul, MA Bethel, HAW Neil, DR Matthews New England Journal of Medicine 359 (15), 1565-1576, 2008 | 1019 | 2008 |
| Addition of biphasic, prandial, or basal insulin to oral therapy in type 2 diabetes RR Holman, KI Thorne, AJ Farmer, MJ Davies, JF Keenan, S Paul, ... New England Journal of Medicine 357 (17), 1716-1730, 2007 | 928 | 2007 |
| Three-year efficacy of complex insulin regimens in type 2 diabetes RR Holman, AJ Farmer, MJ Davies, JC Levy, JL Darbyshire, JF Keenan, ... New England Journal of Medicine 361 (18), 1736-1747, 2009 | 883 | 2009 |
| Citrullinated peptide dendritic cell immunotherapy in HLA risk genotype–positive rheumatoid arthritis patients H Benham, HJ Nel, SC Law, AM Mehdi, S Street, N Ramnoruth, H Pahau, ... Science translational medicine 7 (290), 290ra87-290ra87, 2015 | 374 | 2015 |
| Hypoglycemia and risk of cardiovascular disease and all-cause mortality in insulin-treated people with type 1 and type 2 diabetes: a cohort study K Khunti, M Davies, A Majeed, BL Thorsted, ML Wolden, SK Paul Diabetes care 38 (2), 316-322, 2015 | 374 | 2015 |
| Effects of acarbose on cardiovascular and diabetes outcomes in patients with coronary heart disease and impaired glucose tolerance (ACE): a randomised, double-blind, placebo … RR Holman, RL Coleman, JCN Chan, JL Chiasson, H Feng, J Ge, ... The lancet Diabetes & endocrinology 5 (11), 877-886, 2017 | 324 | 2017 |
| Delay in treatment intensification increases the risks of cardiovascular events in patients with type 2 diabetes SK Paul, K Klein, BL Thorsted, ML Wolden, K Khunti Cardiovascular diabetology 14, 1-10, 2015 | 296 | 2015 |
| Clinical inertia with regard to intensifying therapy in people with type 2 diabetes treated with basal insulin K Khunti, A Nikolajsen, BL Thorsted, M Andersen, MJ Davies, SK Paul Diabetes, Obesity and Metabolism 18 (4), 401-409, 2016 | 278 | 2016 |
| Long-term trends in antidiabetes drug usage in the US: real-world evidence in patients newly diagnosed with type 2 diabetes O Montvida, J Shaw, JJ Atherton, F Stringer, SK Paul Diabetes care 41 (1), 69-78, 2018 | 269 | 2018 |
| A multicenter randomized trial of continuous versus intermittent β-lactam infusion in severe sepsis JM Dulhunty, JA Roberts, JS Davis, SAR Webb, R Bellomo, C Gomersall, ... American journal of respiratory and critical care medicine 192 (11), 1298-1305, 2015 | 249 | 2015 |
| Rationale, design, and organization of a randomized, controlled Trial Evaluating Cardiovascular Outcomes with Sitagliptin (TECOS) in patients with type 2 diabetes and … JB Green, MA Bethel, SK Paul, A Ring, KD Kaufman, DR Shapiro, ... American heart journal 166 (6), 983-989. e7, 2013 | 179 | 2013 |
| Is prolonged infusion of piperacillin/tazobactam and meropenem in critically ill patients associated with improved pharmacokinetic/pharmacodynamic and patient outcomes? An … MH Abdul-Aziz, J Lipman, M Akova, M Bassetti, JJ De Waele, ... Journal of Antimicrobial Chemotherapy 71 (1), 196-207, 2016 | 166 | 2016 |
| Control Group. Intensive glucose control and macrovascular outcomes in type 2 diabetes FM Turnbull, C Abraira, RJ Anderson, RP Byington, JP Chalmers, ... Diabetologia 52 (11), 2288-2298, 2009 | 136 | 2009 |
| Trends in the incidence of diagnosed diabetes: a multicountry analysis of aggregate data from 22 million diagnoses in high-income and middle-income settings DJ Magliano, L Chen, RM Islam, B Carstensen, EW Gregg, ME Pavkov, ... The lancet Diabetes & endocrinology 9 (4), 203-211, 2021 | 124 | 2021 |
| CHHIPS (Controlling Hypertension and Hypotension Immediately Post-Stroke) pilot trial: rationale and design CHHIPS Trial Group Journal of hypertension 23 (3), 649-655, 2005 | 105 | 2005 |
| The effect of renal replacement therapy and antibiotic dose on antibiotic concentrations in critically ill patients: data from the multinational sampling antibiotics in renal … JA Roberts, GM Joynt, A Lee, G Choi, R Bellomo, S Kanji, MY Mudaliar, ... Clinical Infectious Diseases 72 (8), 1369-1378, 2021 | 103 | 2021 |
| Efficacy and safety of traditional Chinese medicine for diabetes: a double-blind, randomised, controlled trial L Ji, X Tong, H Wang, H Tian, H Zhou, L Zhang, Q Li, Y Wang, H Li, M Liu, ... PloS one 8 (2), e56703, 2013 | 102 | 2013 |
Kamlesh KhuntiProfessor of Primary Care Diabetes and Vascular Medicine, University of LeicesterVerified email at le.ac.uk
